$ELV SEC Filings

Filed On	Filing
23 Oct 2026	Form 4: Kaye Mark, EVP & CFO Sold 10,584 shares ($4.66M)
22 Oct 2026	144
21 Oct 2026	10-Q
21 Oct 2026	8-K: Results of Operations and Financial Condition Indianapolis, IN - October 21, 2026 - Elevance Health, Inc. (NYSE: ELV) reported third quarter 2026 results ahead of expectations.
06 Oct 2026	Form 4: Kaye Mark, EVP & CFO Gave up 4,161 shares to cover exercise price or tax ($1.61M) · Received 2,627 shares as a grant or award
10 Sep 2026	8-K: Regulation FD Disclosure Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
04 Sep 2026	Form 4: Wessling Erin M, EVP & Chief Legal Officer Gave up 94 shares to cover exercise price or tax ($38.1K) · Gave up 255 shares to cover exercise price or tax ($106K)
04 Sep 2026	Form 4: Craig Ryan R, EVP & Chief HR Officer Gave up 144 shares to cover exercise price or tax ($58.4K)
17 Jul 2026	Form 4: Peru Ramiro G, Director Bought 1,000 shares ($366K)
17 Jul 2026	Form 4: Boudreaux Gail, Director Bought 2,725 shares ($1M)
15 Jul 2026	10-Q
15 Jul 2026	8-K: Results of Operations and Financial Condition
07 Jul 2026	144
17 Jun 2026	11-K
17 Jun 2026	11-K
15 Jun 2026	Form 4: Penczek Ronald W, CAO & Controller Sold 369 shares ($149K)
12 Jun 2026	144
12 Jun 2026	Form 4: Dixon Robert L Jr, Director Sold 151 shares ($60.7K)
11 Jun 2026	144
10 Jun 2026	8-K: Regulation FD Disclosure

Comments